222 related articles for article (PubMed ID: 32592800)
21. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
[TBL] [Abstract][Full Text] [Related]
22. Interruption of nonviable pregnancies of 24-28 weeks' gestation using medical methods: release date June 2013 SFP guideline #20133.
Perritt JB; Burke A; Edelman AB
Contraception; 2013 Sep; 88(3):341-9. PubMed ID: 23756114
[TBL] [Abstract][Full Text] [Related]
23. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
[TBL] [Abstract][Full Text] [Related]
24. Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.
Gemzell-Danielsson K; Lalitkumar S
Reprod Health Matters; 2008 May; 16(31 Suppl):162-72. PubMed ID: 18772097
[TBL] [Abstract][Full Text] [Related]
25. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Goh SE; Thong KJ
Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
[TBL] [Abstract][Full Text] [Related]
26. [Mifepristone for induction of second trimester abortion].
Heimstad R; Backe B
Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2412-3. PubMed ID: 14560764
[TBL] [Abstract][Full Text] [Related]
27. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
[TBL] [Abstract][Full Text] [Related]
28. One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
Sium AF; Teklu H; Reeves M; Tolu LB; Prager S
Contraception; 2024 Apr; 132():110356. PubMed ID: 38151223
[TBL] [Abstract][Full Text] [Related]
29. Different dosing intervals of mifepristone-misoprostol for second-trimester termination of pregnancy: A meta-analysis and systematic review.
Wu L; Xiong W; Zeng M; Yan A; Song L; Chen M; Wei T; Zu Q; Zhang J
Int J Gynaecol Obstet; 2021 Aug; 154(2):195-203. PubMed ID: 33332580
[TBL] [Abstract][Full Text] [Related]
30. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
[TBL] [Abstract][Full Text] [Related]
31. Complication rates of dilation and evacuation and labor induction in second-trimester abortion for fetal indications: A retrospective cohort study.
Jacques L; Heinlein M; Ralph J; Pan A; Nugent M; Kaljo K; Farez R
Contraception; 2020 Aug; 102(2):83-86. PubMed ID: 32360665
[TBL] [Abstract][Full Text] [Related]
32. Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
Dickinson JE; Doherty DA
Contraception; 2023 Sep; 125():110080. PubMed ID: 37245784
[TBL] [Abstract][Full Text] [Related]
33. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
el-Refaey H; Hinshaw K; Templeton A
Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
[TBL] [Abstract][Full Text] [Related]
34. Mifepristone in second-trimester medical abortion: a randomized controlled trial.
Kapp N; Borgatta L; Stubblefield P; Vragovic O; Moreno N
Obstet Gynecol; 2007 Dec; 110(6):1304-10. PubMed ID: 18055725
[TBL] [Abstract][Full Text] [Related]
35. The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation.
Fiala C; Swahn ML; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2005 Nov; 20(11):3072-7. PubMed ID: 16055455
[TBL] [Abstract][Full Text] [Related]
36. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost.
le Roux PA; Pahal GS; Hoffman L; Nooh R; El-Refaey H; Rodeck CH
Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):52-4. PubMed ID: 11267720
[TBL] [Abstract][Full Text] [Related]
37. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
[TBL] [Abstract][Full Text] [Related]
38. Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks' gestation: a case series and systematic review of the literature.
Kiley J; Turner A; Nosal C; Beestrum M; Dungan J
Eur J Contracept Reprod Health Care; 2022 Dec; 27(6):486-493. PubMed ID: 35899830
[TBL] [Abstract][Full Text] [Related]
39. Flexible mifepristone and misoprostol administration interval for first-trimester medical termination.
Wedisinghe L; Elsandabesee D
Contraception; 2010 Apr; 81(4):269-74. PubMed ID: 20227541
[TBL] [Abstract][Full Text] [Related]
40. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
